DHBUF (Delivra Health Brands) PB Ratio: 1.03 (As of Jul. 01, 2026) — 31% Below Median


What is Delivra Health Brands PB Ratio?

Delivra Health Brands DHBUF PB Ratio is 1.03 as of Jul. 01, 2026, which is 31% below its 10-year median of 1.49. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Delivra Health Brands ranks better than 74.13% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-01), Delivra Health Brands's share price is $0.0708. Delivra Health Brands's Book Value per Share for the quarter that ended in Mar. 2026 was $0.07. Hence, Delivra Health Brands's PB Ratio of today is 1.03.

Good Sign:

Delivra Health Brands Inc stock PB Ratio (=1.06) is close to 2-year low of 0.99.

The historical rank and industry rank for Delivra Health Brands's PB Ratio or its related term are showing as below:

DHBUF' s PB Ratio Range Over the Past 10 Years
Min: 0.12   Med: 1.49   Max: 5.68
Current: 1.01

During the past 13 years, Delivra Health Brands's highest PB Ratio was 5.68. The lowest was 0.12. And the median was 1.49.

DHBUF's PB Ratio is ranked better than
74.13% of 920 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs DHBUF: 1.01

During the past 12 months, Delivra Health Brands's average Book Value Per Share Growth Rate was -30.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -34.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Delivra Health Brands was 303.50% per year. The lowest was -69.60% per year. And the median was -22.50% per year.

Back to Basics: PB Ratio


Delivra Health Brands  (OTCPK:DHBUF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Delivra Health Brands PB Ratio Related Terms


Delivra Health Brands PB Ratio Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands PB Ratio Chart

Delivra Health Brands Annual Data
Trend Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.63 1.89 1.11 2.07 1.38

Delivra Health Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 1.38 1.68 1.80 1.46

DHBUF vs ZTS, UTHR: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's PB Ratio distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's PB Ratio falls into.



Delivra Health Brands PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Delivra Health Brands's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.0708/0.069
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 1.03 mean?
Delivra Health Brands (DHBUF) has a PB Ratio of 1.03 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Delivra Health Brands and its competitors. This is 31% below median its historical median of 1.49. Over the past decade, Delivra Health Brands' PB Ratio has ranged from 0.12 to 5.68. According to the industry distribution chart, Delivra Health Brands ranks #238 out of 920 companies in the Drug Manufacturers industry, placing it in the top 25.9%.
Is Delivra Health Brands' PB Ratio too high?
Delivra Health Brands' current PB Ratio of 1.03 is 31% below median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 5.68. The Drug Manufacturers industry median PB Ratio is 1.89. Delivra Health Brands' value of 1.03 is 45.5% below this industry median. Based on the distribution chart, Delivra Health Brands ranks #238 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Delivra Health Brands' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #238 out of 920 companies for PB Ratio. This puts Delivra Health Brands in the upper half of its industry. The industry median PB Ratio is 1.89. Delivra Health Brands' value of 1.03 is 45.5% below this benchmark. Historically, Delivra Health Brands' own PB Ratio has ranged from 0.12 to 5.68 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 1.89, Delivra Health Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.89, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current PB Ratio of 1.03 is 45.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current PB Ratio is 1.03, which is 31% below median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 62.7% below its estimated fair value. The current PB Ratio is 1.03, which is 31% below median its 10-year median of 1.49 and 45.5% below the Drug Manufacturers industry median of 1.89. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current PB Ratio is 1.03 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delivra Health Brands Business Description

Other Exchanges 3F0:GermanyDHB:Canada
Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.